PsA Secukinumab XCT Structural Progression Study
Clinical trial NCT03623867 · COMPLETED
Trial details
- NCT number
- NCT03623867
- Sponsor
- Chinese University of Hong Kong
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-18
- Primary completion
- 2022-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.